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The existence of a relationship between cancer
a nd heredity has been recognized for years, but only
recently has emerging knowledge in this area enabled
physicians to detect and treat cancer earlier in affected individuals and to prevent its occurrence in
others.
The genetics of human cancer can be divided
into three categories: first, cancers inherited by direct
gene transmission; second, familial disorders not
characterized by malignant disease themselves but
which predispose to an increased likelihood of developing cancer; third, cancers of one or more types
occurring with an increased incidence within a family
but with a mode of genetic transmission that may not
be clear.
A relatively small proportion of cancers are inherited as a result of direct single gene tra nsmission .
One example is retinoblastoma, a highly malignant
tumor of the eye which presents in early childhood,
and which occurs in two different forms. The less
common familial form of the disease is usually transmitted as a highly penetrant dominant trait, with affected individuals often having bilateral involvement
and a somewhat earlier age of onset. The more common form is characteristically sporadic, with affected
individuals having unilateral disease and a later age
of onset.' As more affected persons will now reach
a dulthood and reproduce because of improved treatment, clarification of the mode of inheritance is
m a ndatory to allow proper genetic counseling.
Multiple endocrine adenomatosis type II or
Sipple syndrome consists of the association of medullary carcinoma of the thyroid, pheochromocytoma,
and parathyroid hyperplasia. This disorder appears
to be inherited as an autosomal dominant but with
incomplete penetrance. As with many inherited can-
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cers, there is an increased incidence of bilateral organ
involvement. Clinically, the patient m ay present with
evidence of carcinoma in only one system; for example, medullary carcinoma of the thyroid may be
present without a palpable thyroid nodule. However,
appropriate testing may show occult disease in the
other organs. An elevated serum calcitonin level may
suggest a n occult cancer in predisposed individuals2;
therefore, diagnosis of any of the features of this
unusual syndrome should lead to careful exclusion of
the others, as well as to a search among close relatives
for additional, possibly presymptomatic, cases.
Familial polyposis coli is an a utosomal domina nt disorder in which adenomatous polyps may be
so numerous that they actually carpet the entire colon
and rectum; Gardner syndrome is a distinct variant
that includes associated sebaceous cysts a nd osteomas of bone. Early recognition of these disorders is
critical since virtually I 00% of affected persons will
develop carcinoma of the colon by age 50 unless a
prophylactic colectomy is performed. 3 A number of
oncologists now recommend total colectomy as soon
as the disorder is discovered in childhood unless it is
possible to follow the affected child with regular sigmoidoscopies and barium enemas. The management
of these families can be extremely d ifficult since it is
essential both to stress the importance of regular
examination and to avoid contributing to a n obsessive cancer phobia.
Neurofibromatosis is a n a utosom al dominant
disorder characterized by cafe au lait spots and multiple neurofibromas. The neurofibromas show a sarcomatous degeneration in about I 0% of patients, and
there is an increased risk of gliomas of the brain or
optic nerve, meningiomas, aco ustic neuromas, a nd
pheochromocytomas.
Xeroderma pigmentosa is a rare disorder manifested by sun sensitivity a nd the development of
freckles on sun-exposed areas which then become dry
and scaly. Basa l cell and squamous cell carcinomas of
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the skin later develop, and even if they are arrested,
affected individuals have an increased risk of melanoma. 1 Xeroderma pigmentosa is transmitted as an
autosomal recessive trait. The defect has been shown
to be a specific deficiency in one of the several enzymes normally required to repair ultraviolet radiation damage to the DNA of epidermal cells. 4 When
the precipitating causes of the problem are appreciated, the physician can teach affected individuals to
protect themselves from the carcinogenic effects of
ultraviolet radiation without undue disruption of a
normal lifestyle. 5
Immune deficiency disorders are associated with
an increased incidence of cancer, particularly lymphoma. The prime examples are the recessively inherited syndromes such as X-linked agammaglobulinemia, ataxia telangiectasia, and Wiskott-Aldrich
syndrome. Individually, each of these recessive syndromes is rare, and in the aggregate, affected homozygotes (or hemizygotes if the trait is X-linked) constitute only a small proportion of all patients who
develop cancer. However, there is increasing evidence
that heterozygous carriers of at least some of these
recessive genes may also be predisposed to cancer.
Carriers of rare recessive genes are, of course, much
more numerous in the general population than are
affected homozygotes; in fact, the rarer the recessive
trait, the greater the relative frequency of heterozygous carriers in the population in comparison with
affected homozygotes. Therefore, a small effect of
cancer risk in heterozygotes could have much greater
public health significance than would a major effect
in homozygotes. Swift6 has provided convincing evidence that heterozygous carriers of the genes for
ataxia telangiectasia and Fanconi anemia have a
three- to fourfold increased risk of developing cancer;
he has estimated that at least 3% of all cancers arise in
individuals who are heterozygous for one or the other
of these two genes alone. At present, no laboratory
test is available to identify carriers.
Detecting an increased familial risk of cancer
and following the involved family members for evidence of developing neoplasia is an important activity for practicing physicians. The cancers may be
always of the same organ, that is, a site-specific tumor
may occur in familial aggregations, or they may be of
multiple varied organs. The Table lists the site-specific malignant neoplasms with possible familial occurrence.7
There is considerable heterogeneity in the genetics of certain cancers, especially breast cancer.

155
Neoplasms with Possible Familial Occurrence

Breast
Colon
Stomach
Prostate
Endometrium
Hodgkin disease
Waldenstrom disease
Multiple myeloma
Leukemia

Lymphoma
Hepatocellular tumors
Testicular tumors
Neuroblastoma
Wilmstumor
Burkitt lymphoma
Bronchogenic carcinoma
Ovarian carcinoma

Studies8 - 10 have helped elucidate some of the risk
factors. It is important to know whether the disease
has occurred in two or more female first-degree relatives, whether the disease was pre- or post-menopausal in onset, and whether it was bilateral. In
the premenopausal age group, the relative risk of
breast cancer among family members of an affected
individual is approximately three times that of controls, whereas in the postmenopausal age group, the
risk is only slightly greater than that of controls.
Relatives of women with bilateral disease have a fivefold risk compared to controls. The relatives of
women with premenopausal and bilateral disease
have a relative risk of developing breast cancer that is
almost nine times greater than that of controls, while
the relatives of patients with postmenopausal bilateral disease have a risk that is four times greater. The
risk to other family members also depends upon the
relationship of prior affected persons to the proband.
For example, if prior disease involved a proband's
mother, the proband's sisters will have a 30% incidence of cancer in the 20-to 29-year age group, a
risk 47 times greater than that of the general population . Clearly, these facts imply a genetic factor in
breast cancer which appears most consistent with
polygenic inheritance of a predisposition. Physician
recognition of and response to this inherited predisposition is important particularly in the high-risk
situation. In one such family, for example, bilateral
reduction mammoplasty with implantation of a subcutaneous prosthesis was recommended for a 19year-old girl whose two sisters, mother, and maternal
grandmother had had early onset of breast cancer. 11
The concept of "cancer families" has been
broadened to include kindreds displaying familial occurrence of diverse neoplasms even of dissimilar cell
types. 12 The cancer family has the following characteristics: I) an increased occurrence of adenocarcinoma primarily of colon and endometrium; 2) in-
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creased frequency of multiple primary malignant
neoplasms; 3) early age of onset of cancer relative to
the usual age of onset of that cancer in the general
population; 4) vertical transmission of cancer consistent with an autosomal dominant inheritance pattern.
One such family has been described in Virginia. 13
Environmental factors may also influence expression of the disease when there is a familial tendency to cancer. Studies by Tokuhata have confirmed
an increased incidence of cancer of the lung in relatives of patients with lung cancer, and his data suggest that the combined risk of cigarette smoking and
the familial host factor increase the liability of developing lung cancer in a synergistic rather than additive
manner. 1•
The interrelationships between heredity and environment in the occurrence of cancer are complex
and in many cases not completely characterized, but
certain facts are clear. Specific cancers can be inherited directly . Certain diseases that predispose to cancer are inherited, and specific cancers or specific tendencies to develop a variety of cancers are inherited
in families. Examples of each of these have been
discussed. The long-range challenge to physicians is
to recognize these situations and to study them thoroughly to further our understanding of the causes of
cancer. More immediately, however, the alert physician who takes a detailed family history can recognize
the increased risk of a particular malignancy and, by
careful examination, testing, advice, and follow-up,
can provide early treatment or even prevent the development of a potentially fatal malignancy. 11
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